Immunosuppression by 2' deoxycoformycin: studies on the mode of administration.
D000243:Adenosine Deaminase / Q000378:metabolism; D000818:Animals; D001835:Body Weight; D003070:Coformycin / Q000008:administration & dosage* / Q000031:analogs & derivatives / Q000494:pharmacology; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008198:Lymph Nodes / Q000033:anatomy & histology / Q000201:enzymology / Q000473:pathology; D008213:Lymphocyte Activation; D008231:Lymphopenia / Q000209:etiology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008934:Mitogens / Q000494:pharmacology; D009929:Organ Size; D015649:Pentostatin; D012263:Ribonucleosides / Q000008:administration & dosage*; D013154:Spleen / Q000033:anatomy & histology / Q000201:enzymology / Q000473:pathology; D013950:Thymus Gland / Q000033:anatomy & histology / Q000201:enzymology / Q000473:pathology
D007166:Immunosuppressive Agents; D008934:Mitogens; D012263:Ribonucleosides; D003070:Coformycin; D015649:Pentostatin; D000243:Adenosine Deaminase